Pediatric Studies Could Be Required For Most Lymphomas, Leukemia
Executive Summary
FDA may invoke the pediatric rule to require studies for most lymphomas and leukemias, members of the Oncologic Drugs Advisory Committee's Pediatric Subcommittee recommended April 24.